QuidelOrtho (QDEL) Net Income towards Common Stockholders (2021 - 2024)
QuidelOrtho's (QDEL) quarterly Net Income towards Common Stockholders came in at -$1.7 billion in Q1 2024, down 3595.9% year-on-year from $48.8 million in Q2 2023, and down 222.8% quarter-over-quarter from -$528.5 million in Q4 2023.
QuidelOrtho (QDEL) Net Income towards Common Stockholders (2021 - 2024) Analysis & Trends
QuidelOrtho has disclosed Net Income towards Common Stockholders across 4 years of filings, most recently posting -$1.7 billion for Q1 2024.
- Net Income towards Common Stockholders for Q1 2024 came in at -$1.7 billion, down 3595.9% year-over-year; the trailing twelve-month figure through Dec 2024 was -$1.7 billion (down 212.68% YoY), and the FY2024 annual result was -$2.1 billion, down 20216.83% from the prior year.
- Net Income towards Common Stockholders came in at -$1.7 billion for Q1 2024 at QuidelOrtho, down from -$528.5 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $479.9 million in Q2 2022 to a low of -$1.7 billion in Q1 2024.
- The 4-year median for Net Income towards Common Stockholders is $19.2 million (2022), against an average of -$123.9 million.
- Across the five-year window, Net Income towards Common Stockholders rose 1.05% in 2022 and slumped 3595.9% in 2024, its largest moves.
- QuidelOrtho's Net Income towards Common Stockholders stood at $215.7 million in 2021, then sank by 91.1% to $19.2 million in 2022, then slumped by 2852.6% to -$528.5 million in 2023, then plunged by 222.8% to -$1.7 billion in 2024.
- The last three Net Income towards Common Stockholders figures came in at -$1.7 billion (Q1 2024), -$528.5 million (Q4 2023), and -$12.7 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | QuidelOrtho | 967.08 Mn | 826.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -1.71 Bn |
| Dec 31, 2023 | -528.50 Mn |
| Oct 1, 2023 | -12.70 Mn |
| Jul 2, 2023 | -53.20 Mn |
| Apr 2, 2023 | 48.80 Mn |
| Jan 1, 2023 | 135.80 Mn |
| Oct 2, 2022 | 19.20 Mn |
| Jul 3, 2022 | 19.30 Mn |
| Apr 3, 2022 | 479.90 Mn |
| Oct 3, 2021 | 215.70 Mn |
| Jul 4, 2021 | 19.10 Mn |